Cognitive effects of σ Receptor ligands

Sigma Receptors: Chemistry, Cell Biology and Clinical Implications

Volumn , Issue , 2007, Pages 237-271

  Maurice, Tangui ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64149115714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-36514-5_12     Document Type: Chapter

References (123)

1. Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL. Evidence for an anti-amnesic effect of JO1784 in the rat: A potent and selective ligand for the σ receptor. Brain Res 1991, 546:282-286.
2. Monnet FP, Debonnel G, Junien JL, De Montigny C. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur J Pharmacol 1990, 179:441-445.
3. Maurice T, Lockhart BP. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands. Prog Neuro-Psychopharmacol Biol Psychiatry 1997, 21:69-102.
4. 1 receptor agonist. CNS Drug Rev 1998, 4:1-24.
5. 1) receptor: Pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 1999, 81:125-155.
6. 1)receptor function: Behavioral consequences and therapeutic opportunities. Brain Res Rev 2001, 37:116-132.
7. Phan VL, Su TP, Privat A, Maurice T. Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect the a, receptor- mediated behaviour in mice. Eur J Neurosci 1999, 11:2385-2396.
8. 1) receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther 2001, 298:1269-1279.
9. Baulieu EE. Steroid hormones in the brain: Several mechanisms ? In Steroid Hormone Regulation of the Brain. Fuxe K, Gustafson JA, Wettenberg L., eds. Oxford: Pergamon Press, 1981, pp 3-14.
10. Majewska MD, Mienville JM, Vicini S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 1988, 90:279-284.
11. Majewska MD, DemirgOren S, Spivak CE, London ED. The neurosteroid dehydroepi- Androsterone sulfate is an allosteric antagonist of the GABAa receptor. Brain Res 1990, 526:143-146.
12. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: A positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 1991, 40:333-336.
13. Schumacher M, McEwen BS. Steroid and barbiturate modulation of the GABAa receptor. Mol Neurobiol 1989, 3:275-280.
14. Wu FS, Gibbs TT, Farb DH. Inverse modulation of gamma-aminobutyric acid- And glycine-induced currents by progesterone. Mol Pharmacol 1990, 37:597-602.
15. Smith SS. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience 1991, 42:309-320.
16. Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 240: 219-221.
17. 3H]SKF-10, 047 binding to ct, receptors in the mouse forebrain. J Neurosci Res 1996, 46:734-743.
18. 3H] norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 1995, 92: 3774-3778.
19. Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996, 16:1193-1202.
20. Vallee M, Mayo W, Koob GF, Le Moal M. Neurosteroids in learning and memory processes. Int Rev Neurobiol 2001, 46:273-320.
21. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T. Low dose of l, 3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice. Psychopharmacology 1994, 114:520-522.
22. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 1994, 647:44-56.
23. Maurice T, Hiramatsu M, Kameyama T, Hasegawa T, Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia. Brain Res 1994, 647:57-64.
24. Maurice T, Su TP, Parish DW, Nabeshima T, Privat A. PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav 1994, 49:859-869.
25. Matsuno K, Senda T, Matsunaga K, Mita S, Kaneto H. Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: Comparison with acetylcholinesterase inhibitors. Psychopharmacology 1993, 112:134-141.
26. Matsuno K, Senda T, Matsunaga K, Mita S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: Involvement in the central acetylcholinergic system. Eur J Pharmacol 1994, 261:43-51.
27. 1 receptor agonistic properties. Behav Brain Res 1997, 83:221-224.
28. Morris RG, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
29. Maurice T. Beneficial effect of the CTi receptor agonist PRE-084 against spatial learning deficits in aged rats. Eur J Pharmacol 2001, 431:223-227.
30. Phan VL, Urani A, Sandillon F, Privat A, Maurice T. Preserved sigma-1 (cti) receptor expression and behavioral efficacy in the aged C57BL/6 mouse. Neurobiol Aging 2003, 24:865-881.
31. Zou LB, Yamada K, Nabeshima T. Sigma receptor ligands (+)-SKF 10, 047 and SA4503 improve dizocilpine- induced spatial memory deficits in rats. Eur J Pharmacol 1998, 355:1-10.
32. Zou LB, Yamada K, Sasa M, Nakata Y, Nabeshima T. Effect of Cti receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology 2000, 39:1617-1627.
33. Ohno M, Watanabe S. Intrahippocampal administration of (+)-SKF 10, 047, a a ligand, reverses MK-801-induced impairment of working memory in rats. Brain Res 1995, 684:237-242.
34. Bjorklund A, Dunnett SB. Cognitive function. Acetylcholine revisited. Nature 1995, 375:446.
35. Aigner TG. Pharmacology of memory: Cholinergic-glutamatergic interactions. Curr Opin Neurobiol 1995, 5:155-160.
36. Gallagher M, Colombo PJ. Ageing: The cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995, 5:161-168.
37. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
38. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
39. Glick SD, Zimmerberg B. Amnesic effects of scopolamine. Behav Biol 1972; 7:245-54.
40. Smith CM, Swash M. Possible biochemical basis of memory disorder in Alzheimer disease. Ann Neurol 1978, 3:471-473.
41. McGaugh JL. Drug facilitation of learning and memory. Ann Rev Pharmacol 1973, 13:229-241.
42. Dokla CP, Parker SC, Thai LJ. Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalis magnocellularis lesions. Neuropharmacology 1989, 28:1279-1282.
43. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 1996, 706:181-193.
44. Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroamino-acridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 1986, 315:1241-1245.
45. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. J Am Med Assoc 1992, 268:2523-2529.
46. Leventer SM, Johnson KM. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists. Life Sci 1984, 34:793-801.
47. Cambell BG, Keana JF, Weber E. Sigma receptor ligand N, N'-di-(ortho-tolyl)guanidine inhibits release of acetylcholine in the guinea pig ileum. Eur J Pharmacol 1991, 205:219-223.
48. Junien JL, Roman FJ, Brunelle G, Pascaud X. JO 1784, a novel sigma ligand, potentiates [3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 1991, 200:343-345.
49. Matsuno K, Matsunaga K, Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)A'-allylnormetazocine as measured by brain microdialysis. Brain Res 1992, 575:315-319.
50. Matsuno K, Matsunaga K, Senda T, Mita S. Increase in extracellular acetylcholine level by a ligands in rat frontal cortex. J Pharmacol Exp Ther 1993, 265:851-859.
51. Bowen WD, Kirschner BN, Newman AH, Rice KC. sigma receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain. Eur J Pharmacol 1988, 149:399-400.
52. Candura SM, Coccini T, Manzo L, Costa LG. Interaction of a-compounds with receptor- stimulated phosphoinositide metabolism in the rat brain. J Neurochem 1990, 55:1741-1748.
53. Vargas HM, Pechnick RN. Binding affinity and antimuscarinic activity of sigma and phencyclidine receptor ligands. Eur J Pharmacol 1991, 195:151-156.
54. Izquierdo I. Role ofNMDA receptors in memory. Trends Pharmacol Sci 1991; 12:128-9.
55. McEntee WJ, Crook TH. Glutamate: Its role in learning, memory, and the aging brain. Psychopharmacology 1993, 111:391-401.
56. Bliss TV, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
57. Hawkins RD, Kandel ER, Siegelbaum SA. Learning to modulate transmitter release: Themes and variations in synaptic plasticity. Ann Rev Neurosci 1993, 16:625-665.
58. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996, 87:1327-1338.
59. Parada-Turska J, Turski WA. Excitatory amino-acid antagonists and memory: Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 1990, 29:1111-1116.
60. Venable N, Kelly PH. Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology 1990, 100:215-221.
61. Monnet FP, Blier P, Debonnel G, de Montigny C. Modulation by σ ligands of N-methyl- D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedeberg Arch Pharmacol 1992, 346:32-39.
62. Gonzalez-Alvear GM, Werling LL. Regulation of [3H]dopamine release from rat striatal slices by a receptor ligands. J Pharmacol Exp Ther 1994, 271:212-219.
63. Liang X, Wang RY. Biphasic modulatory action of the selective ct receptor ligand SR31742A on N-methyl-D-aspartate-induced neuronal responses in the frontal cortex. Brain Res 1998, 807:208-213.
64. Monnet FP. sigma receptors and intracellular signaling: Impact on synaptic plasticity? XXIII CINP Meeting Abstr. 2002, S.29.3.
65. Venault P, Charpouthier G, Prado de Carvalho L, Simiand J, Morre M, Dodd RH, Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986, 321:864-866.
66. Starr MS. Multiple opiate receptors may be involved in suppressing gamma- Aminobutyrate release in substantia nigra. Life Sci 1985, 37:2249-2255.
67. Wang Y, Lee HK. Facilitation of gamma-aminobutyric acid-induced depression by (+)PCMP and dexoxadrol in the cerebellar Purkinje neurons of the rat. Neuropharmacology 1989, 28:343-350.
68. Zhang J, Chiodo LA, Freeman AS. Effects of phencyclidine, MK-801 and l, 3-di(2-tolyl) guanidine on non-dopaminergic midbrain neurons. Eur J Pharmacol 1993, 230:371-374.
69. Majewska MD. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann NY Acad Sci 1995, 774:111-120.
70. Demirgoren S, Majewska MD, Spivak CE, London ED. Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAa receptor. Neuroscience 1991, 45:127-135.
71. Spivak CE. Desensitization and noncompetitive blockade of GABAσ receptors in ventral midbrain neurons by a neurosteroid dehydroepiandrosterone sulfate. Synapse 1994, 16:113-122.
72. Wu FS, Chen SC, Tsai JJ. Competitive inhibition of the glycine-induced current by pregnenolone sulfate in cultured chick spinal cord neurons. Brain Res 1997, 750:318-320.
73. Mtchedlishvili Z, Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol 2003, 64:857-864.
74. 1) receptor in the adult rat central nervous system. Neuroscience 2000, 97:155-170.
75. 2+ concentration. J Pharmacol Exp Ther 2000, 293:788-798.
76. Hayashi T, Su TP. Regulating ankyrin dynamics: roles of CTi receptors. Proc Natl Acad Sci USA 2001, 98:491-496.
77. 2+ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994, 269:1300-1309.
78. Novakova M, Ela C, Bowen WD, Hasin Y, Eilam Y. Highly selective sigma receptor ligands elevate inositol 1, 4, 5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 1998, 353:315-317.
79. Nicoll RA, Kauer JA, Malenka RC. The current excitement in long-term potentiation. Neuron 1988, 1:97-103.
80. 2+ channels in hippocampal CA1 neurons. Science 1989, 244:1189-1193.
81. 2+ channels at the base of major dendrites in hippocampal pyramidal neurons. Nature 1990, 347:281-284.
82. Grover LM, Teyler TJ. Two components of long-term potentiation induced by different patterns of afferent activation. Nature 1990, 347:477-479.
83. Deyo RA, Nix DA, Parker TW. Nifedipine blocks retention of a visual discrimination task in chicks. Behav Neural Biol 1992, 57:260-262.
84. Nikolaev E, Kaczmarek L. Disruption of two-way active avoidance behavior by nimodipine. Pharmacol Biochem Behav 1994, 47:757-759.
85. Maurice T, Bayle J, Privat A. Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav Pharmacol 1995, 6:167-175.
86. 1 ) receptor agonists confirmed by in vivo antisense strategy in the mouse. Brain Res 2001a, 898:113-121.
87. 1 ) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense oligodeoxynucleotide strategy in the mouse. Br J Pharmacol 2001, 134:1731-1741.
88. Maurice T, Privat A. SA4503, a novel cognitive enhancer with receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol 1997, 328:9-18.
89. Senda T, Matsuno K, Kobayashi T, Mita S. Reduction of the scopolamine-induced impairment of passive avoidance performance by σ receptor agonist in mice. Physiol Behav 1997, 61:257-264.
90. Flood JF, Smith GE, Roberts E. Dehydroepiandrosterone and its sulphate enhance memory retention in mice. Brain Res 1988, 447:269-278.
91. Li PK, Rhodes ME, Jagannathan S, Johnson DA. Reversal of scopolamine-induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Cog Brain Res 1995, 2:251-254.
92. Meziane H, Mathis C, Paul SM, Ungerer A. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnesic effects in mice performing an appetitive learning task. Psychopharmacology 1996, 126:323-330.
93. 1 ) receptors. Brain Res 1998, 799:64-77.
94. Bouchard P, Maurice T, St-Pierre S, Privat A, Quirion R. Neuropeptide Y and calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a ct receptor-related mechanism. Eur J Neurosci 1997, 9:2142-2151.
95. Bouchard P, Dumont Y, Fournier A, St-Pierre S, Quirion, R. Evidence for in vivo interactions between neuropeptide Y-related peptides and o receptors in the mouse hippocampal formation. J Neurosci 1993, 13:3926-3931.
96. Bouchard P, Monnet F, Bergeron R, Roman F, Junien JL, de Montigny C, Debonnel G, Quirion R. In vivo modulation of a receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: Radioligand binding and electrophysiological studies. Eur J Neurosci 1995, 7:1952-1962.
97. Bouchard P, Roman F, Junien JL, Quirion R. Autoradiographic evidence for the modulation of in vivo a receptor labelling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain. J Pharmacol Exp Ther 1996, 276:223-230.
98. Maurice T, Junien JL, Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine induced learning impairment in mice via arreceptors. Behav Brain Res 1997, 83:159-164.
99. Maurice T, Su TP, Parish DW, Privat A. Prevention of nimodipine-induced impairment of learning by the selective a ligand PRE-084. J Neural Transm 1995, 102:1-18.
100. 1 ligands. Synapse 1998, 29:62-71.
101. 2 sites. Br J Pharmacol 1999a, 127:335-342.
102. Nabeshima K, Katoh A, Ishimaru I, Yoneda Y, Ogita K, Murase K, Ohtsuka H, Inari K, Fukuta T, Kameyama T. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J Pharmacol Exp Ther 1991, 256:378-384.
103. Brown AW, Aldridge WN, Street BW, Verschoyle RD. The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. Am J Pathol 1979, 97:59-82.
104. Chang LW, Dyer RS. A time-course study of trimethyltin induced neuropathology in rats. Neurobehav Toxicol Teratol 1983, 5:443-459.
105. Hagan JJ, Jansen JHM, Broekkamp CLE. Selective behavioural impairment after acute intoxication with trimethyltin (TMT) in rats. Neurotoxicology 1988, 9:53-74.
106. Matsumoto RR, Hemstreet MK, Lai NL, Thurkauf A, de Costa BR, Rice KC, Hellewell SB, Bowen WD, Walker JM. Drug specificity of pharmacological dystonia. Pharmacol Biochem Behav 1990, 36:151-155.
107. 1 receptors in the rat brain. Ann Nucl Med 2003, 17:73-77.
108. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991, 6:487-498.
109. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996, 315:1-10.
110. Senda T, Matsuno K, Kobayashi T, Nakazawa N, Nakata K, Mita S. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats. Pharmacol Biochem Behav 1998, 59:129-134.
111. 1) receptor agonists and neurosteroids attenuate β-25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998, 83:413-428.
112. 1) receptor agonists. Drugs News Perspect 2002, 15:617-625.
113. 1) receptor agonists in β-25-35-amyloid peptide-treated mice. Behav Brain Res 2002, 134:239-247.
114. Flood JF, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 1988, 448:178-183.
115. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, Koehl M, Le Moal M. Baulieu EE, Robel P, Simon H. Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 1997, 94:14865-14870.
116. 3H]DTG are elevated in aged Fisher-344 x Brown Norway (Fl) rats. Synapse 2000, 35:311-3.
117. Kawamura K, Kimura Y, Tsukada H, Kobayashi T, Nishiyama S, Kakiuchi T, Ohba H, Harada N, Matsuno K, Ishii K, Ishiwata K. An increase of at receptors in the aged monkey brain. Neurobiol Aging 2003, 24:745-752.
118. Maurice T, Roman FJ, Su TP, Privat A. Beneficial effects of a agonists on the age- related learning impairment in senescence-accelerated mouse (SAM). Brain Res 1996, 733:219-230.
119. Tottori K, Nakai M, Uwahodo Y, Miwa T, Yamada S, Oshiro Y, Kikuchi T, Altar A. Attenuation of scopolamine-induced and age-associated memory impairments by the σ and 5-hydroxytryptamine-1A receptor agonist OPC-14523 (1-(3[4-(3-chlorophenyl)-1 piperazinyl]propyl)-5-methoxy-3, 4-dihydro-2[1H]-quinolinone monomethanesulfonate). J Pharmacol Exp Ther 2002, 301:249-257.
120. Phan VL, Miyamoto Y, Nabeshima T, Maurice T. Age-related expression and antidepressant efficacy of sigmal (al) receptors in the senescence-accelerated (SAM) mouse. J Neurosci Res 2005, 79:561-572.
121. Phan VL, Urani A, Romieu P, Maurice T. Strain differences in σ receptor-mediated behaviours are related to neurosteroid levels. Eur J Neurosci 2002, 15:1423-1434.
122. Matsuno K, Senda T, Kobayashi T, Murai M, Mita S. Reduction of 4-cyclohexyl-1- [(1R)-1, 2-diphenylethyl]-piperazine-induced memory impairment of passive avoidance performance by σ receptor agonists in mice. Meth Find Exp Clin Pharmacol 1998, 20:575-580.
123. Reddy DS, Kulkarni SK. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res 1998, 791:108-116.